Diagnostic accuracy of the ID migraine: A systematic review and meta-analysis

Headache

Volumn 51, Issue 7, 2011, Pages 1140-1148

  Cousins, Gráinne ^a   Hijazze, Samira ^a,b   Van De Laar, Floris A ^b   Fahey, Tom ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ID Migraine; migraine disorders; sensitivity and specificity

Indexed keywords

DIAGNOSTIC ACCURACY; HUMAN; IDENTIFICATION OF MIGRAINE; MEDICAL DECISION MAKING; META ANALYSIS; MIGRAINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; VALIDATION STUDY;

HUMANS; MIGRAINE DISORDERS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 79960566665     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01916.x     Document Type: Review

References (29)

1. Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB,. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia. 2003; 23: 519-527. (Pubitemid 37114973)
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M,. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001; 41: 646-657. (Pubitemid 32777747)
3. Menken M, Munsat TL, Toole JF,. The global burden of disease study: Implications for neurology. Arch Neurol. 2000; 57: 418-420. (Pubitemid 30140537)
4. Pradalier A, Auray JP, El Hasnaoui A, et al,. Economic impact of migraine and other episodic headaches in France: Data from the GRIM2000 study. Pharmacoeconomics. 2004; 22: 985-999. (Pubitemid 39472624)
5. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML,. Burden of migraine in the United States: Disability and economic costs. Arch Intern Med. 1999; 159: 813-818. (Pubitemid 29200307)
6. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF,. Migraine in the United States: epidemiology and patterns of health care use. Neurology. 2002; 58: 885-894. (Pubitemid 34242063)
7. Celentano DD, Stewart WF, Lipton RB, Reed ML,. Medication use and disability among migraineurs: A national probability sample survey. Headache. 1992; 32: 223-228.
8. Sadovsky R, Dodick DW,. Identifying migraine in primary care settings. Am J Med. 2005; 118 (Suppl. 1): 11S-17S.
9. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988; 8: 1-96.
10. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders; 2nd edition. Cephalalgia. 2004; 24: 9-160.
11. Smetana GW,. The diagnostic value of historical features in primary headache syndromes: A comprehensive review. Arch Intern Med. 2000; 160: 2729-2737.
12. Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM,. Does this patient with headache have a migraine or need neuroimaging? JAMA. 2006; 296: 1274-1283. (Pubitemid 44394899)
13. Lipton RB, Dodick D, Sadovsky R, et al,. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003; 61: 375-382. (Pubitemid 36975969)
14. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol. 2009; 62: 1006-1012.
15. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J,. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003; 3: 25.
16. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J,. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006; 6: 9.
17. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH,. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005; 58: 982-990. (Pubitemid 41316441)
18. Deeks JJ, Altman DG,. Diagnostic tests 4: Likelihood ratios. BMJ. 2004; 329: 168-169.
19. Brighina F, Salemi G, Fierro B, et al,. A validation study of an Italian version of the "ID Migraine. Headache. 2007; 47: 905-908. (Pubitemid 46944379)
20. Gil-Gouveia R, Martins I,. Validation of the Portuguese version of ID-Migraine. Headache. 2010; 50: 396-402.
21. Karli N, Ertas M, Baykan B, et al,. The validation of ID Migraine screener in neurology outpatient clinics in Turkey. J Headache Pain. 2007; 8: 217-223. (Pubitemid 350020774)
22. Kim ST, Kim CY,. Use of the ID Migraine questionnaire for migraine in TMJ and Orofacial Pain Clinic. Headache. 2006; 46: 253-258.
23. Di Piero V, Altieri M, Conserva G, Petolicchio B, Di Clemente L, Hettiarachchi J,. The effects of a sensitisation campaign on unrecognised migraine: The Casilino study. J Headache Pain. 2007; 8: 205-208. (Pubitemid 350020772)
24. Di Paolo C, Di Nunno A, Vanacore N, Bruti G,. ID migraine questionnaire in temporomandibular disorders with craniofacial pain: A study by using a multidisciplinary approach. Neurol Sci. 2009; 30: 295-299.
25. Siva A, Zarifoglu M, Ertas M, et al,. Validity of the ID-Migraine screener in the workplace. Neurology. 2008; 70: 1337-1345. (Pubitemid 351550338)
26. Zarifoglu M, Karli N, Taskapilioglu O,. Can ID Migraine be used as a screening test for adolescent migraine? Cephalalgia. 2008; 28: 65-71. (Pubitemid 350212656)
27. Khu JV, Siow HC, Ho KH,. Headache diagnosis, management and morbidity in the Singapore primary care setting: Findings from a general practice survey. Singapore Med J. 2008; 49: 774-779.
28. Ertas M, Baykan B, Tuncel D, et al,. A comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics. Cephalalgia. 2009; 29: 68-75.
29. Ebell MH,. Diagnosis of migraine headache. Am Fam Physician. 2006; 74: 2087-2088. (Pubitemid 44927022)